Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Merlino

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|March 14, 2024
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndromeGaia Pellitteri, Salvatore Versace, Giovanni Merlino, et al.
Journal of Thrombosis and Thrombolysis|October 25, 2017
CHA<sub>2</sub>DS<sub>2</sub>-VASc score predicts short- and long-term outcomes in patients with acute ischemic stroke treated with intravenous thrombolysisGiovanni Merlino, Michele Rana, Sara Naliato, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 8, 2009
Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndromeGiovanni Merlino, Anna Serafini, Jeong Jin Young, et al.
Expert Review of Neurotherapeutics|July 2, 2019
Timing use of novel anti-epileptic drugs: is earlier better?Stefano de Biase, Annacarmen Nilo, Andrea Bernardini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 8, 2005
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapyGiovanni Merlino, Antonella Piani, Pierluigi Dolso, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2010
A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failureGiovanni Merlino, Simone Lorenzut, Gian Luigi Gigli, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 31, 2024
Milvexian, a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluationAlessandro Marè, Arianna Cella, Yan Tereshko, et al.
Frontiers in Neurology|June 30, 2022
Stress Hyperglycemia Does Not Affect Clinical Outcome of Diabetic Patients Receiving Intravenous Thrombolysis for Acute Ischemic StrokeGiovanni Merlino, Sara Pez, Yan Tereshko, et al.
Multiple Sclerosis and Related Disorders|February 1, 2021
Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatmentRiccardo Garbo, Simone Lorenzut, Ilaria Del Negro, et al.
Frontiers in Neurology|April 25, 2022
Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case ReportsEnrico Belgrado, Ilaria Del Negro, Daniele Bagatto, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Expert Opinion on Drug Metabolism & Toxicology|March 14, 2024
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndromeGaia Pellitteri, Salvatore Versace, Giovanni Merlino, et al.
Journal of Thrombosis and Thrombolysis|October 25, 2017
CHA<sub>2</sub>DS<sub>2</sub>-VASc score predicts short- and long-term outcomes in patients with acute ischemic stroke treated with intravenous thrombolysisGiovanni Merlino, Michele Rana, Sara Naliato, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 8, 2009
Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndromeGiovanni Merlino, Anna Serafini, Jeong Jin Young, et al.
Expert Review of Neurotherapeutics|July 2, 2019
Timing use of novel anti-epileptic drugs: is earlier better?Stefano de Biase, Annacarmen Nilo, Andrea Bernardini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 8, 2005
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapyGiovanni Merlino, Antonella Piani, Pierluigi Dolso, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2010
A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failureGiovanni Merlino, Simone Lorenzut, Gian Luigi Gigli, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 31, 2024
Milvexian, a novel factor XIa inhibitor for stroke prevention: pharmacokinetic and pharmacodynamic evaluationAlessandro Marè, Arianna Cella, Yan Tereshko, et al.
Frontiers in Neurology|June 30, 2022
Stress Hyperglycemia Does Not Affect Clinical Outcome of Diabetic Patients Receiving Intravenous Thrombolysis for Acute Ischemic StrokeGiovanni Merlino, Sara Pez, Yan Tereshko, et al.
Multiple Sclerosis and Related Disorders|February 1, 2021
Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatmentRiccardo Garbo, Simone Lorenzut, Ilaria Del Negro, et al.
Frontiers in Neurology|April 25, 2022
Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case ReportsEnrico Belgrado, Ilaria Del Negro, Daniele Bagatto, et al.
Pageof 14